These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 25616854)

  • 1. IOM report calls for culture of data sharing.
    Cancer Discov; 2015 Mar; 5(3):219-20. PubMed ID: 25616854
    [No Abstract]   [Full Text] [Related]  

  • 2. IOM outlines framework for clinical data sharing, solicits input.
    Kuehn BM
    JAMA; 2014 Feb; 311(7):665. PubMed ID: 24549533
    [No Abstract]   [Full Text] [Related]  

  • 3. Sharing clinical trial data: maximizing benefits, minimizing risk.
    Lo B
    JAMA; 2015 Feb; 313(8):793-4. PubMed ID: 25594500
    [No Abstract]   [Full Text] [Related]  

  • 4. Doubters ask if IOM report will foster more sharing of clinical trial data.
    Rice S
    Mod Healthc; 2015 Jan; 45(3):10. PubMed ID: 25671895
    [No Abstract]   [Full Text] [Related]  

  • 5. IOM suggests ways to share clinical trial data.
    Wanniarachige D
    CMAJ; 2015 Feb; 187(3):168-169. PubMed ID: 25623645
    [No Abstract]   [Full Text] [Related]  

  • 6. Sharing individual patient data from clinical trials.
    Drazen JM
    N Engl J Med; 2015 Jan; 372(3):201-2. PubMed ID: 25587944
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical medicine. Biomarker tests need closer scrutiny, IOM concludes.
    Kaiser J
    Science; 2012 Mar; 335(6076):1554. PubMed ID: 22461579
    [No Abstract]   [Full Text] [Related]  

  • 8. IOM report.
    Bolhouse L
    Okla Nurse; 2011; 56(1):19. PubMed ID: 21473423
    [No Abstract]   [Full Text] [Related]  

  • 9. IOM report calls for a more streamlined, faster cancer cooperative trials program.
    Kuehn BM
    JAMA; 2010 Jun; 303(21):2126-7. PubMed ID: 20516407
    [No Abstract]   [Full Text] [Related]  

  • 10. IOM calls for transformation of attitudes toward pain and its prevention and management.
    Institute of Medicine
    J Pain Palliat Care Pharmacother; 2012; 26(1):40-3. PubMed ID: 22448940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical trial data: share and share alike?
    Mitka M
    JAMA; 2015 Mar; 313(9):881-2. PubMed ID: 25734721
    [No Abstract]   [Full Text] [Related]  

  • 12. The knowledge translation paradigm: historical, philosophical, and practice perspectives.
    Hedges JR
    Acad Emerg Med; 2007 Nov; 14(11):924-7. PubMed ID: 17704350
    [No Abstract]   [Full Text] [Related]  

  • 13. Beyond myalgic encephalomyelitis/chronic fatigue syndrome: an IOM report on redefining an illness.
    Clayton EW
    JAMA; 2015 Mar; 313(11):1101-2. PubMed ID: 25668027
    [No Abstract]   [Full Text] [Related]  

  • 14. The complementary and alternative medicine controversy continues: the IOM report.
    Lipman AG
    J Pain Palliat Care Pharmacother; 2005; 19(4):5-9. PubMed ID: 16431827
    [No Abstract]   [Full Text] [Related]  

  • 15. National Cancer Institute begins revamp of Clinical Trials Cooperative Program.
    Kuehn BM
    JAMA; 2011 Feb; 305(8):767-8. PubMed ID: 21343570
    [No Abstract]   [Full Text] [Related]  

  • 16. Future oversight of recombinant DNA research: recommendations of an Institute of Medicine committee.
    Gostin LO; Altevogt BM; Pope AM
    JAMA; 2014 Feb; 311(7):671-2. PubMed ID: 24435443
    [No Abstract]   [Full Text] [Related]  

  • 17. The IOM pain report revisited: setting the stage for what's next in transforming pain care, education and research.
    Mackey S
    Pain Med; 2014 Jun; 15(6):885-6. PubMed ID: 24964915
    [No Abstract]   [Full Text] [Related]  

  • 18. Perspectives. IOM: NIH needs big strategy, not fewer institutes.
    Med Health; 2003 Aug; 57(29):7-8. PubMed ID: 12934435
    [No Abstract]   [Full Text] [Related]  

  • 19. Science and government. Review for NCCAM is overdue.
    Marcus DM; Grollman AP
    Science; 2006 Jul; 313(5785):301-2. PubMed ID: 16857923
    [No Abstract]   [Full Text] [Related]  

  • 20. IOM report recommends continued CAM research and stricter regulation of dietary supplements.
    Horrigan BJ
    Explore (NY); 2005 May; 1(3):159-65. PubMed ID: 16781522
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.